Skip to main content

Table 4 ADNI QT-PAD Participant Characteristics. Gender, age (in years), education (in years), and genetic dosage of the APOE ε4 allele at the baseline are shown

From: Genome-Wide association study of quantitative biomarkers identifies a novel locus for alzheimer’s disease at 12p12.1

Diagnosis

HC

MCI

AD

N/A

Number

461

797

312

6

Gender (% Female)

49.67

40.15

42.95

black66.67

Age (Mean ±std)

74.47 ±5.68

73.09 ±7.54

75.18 ±7.79

72.15 ±8.29

Education (Mean ±std)

16.42 ±2.65

16.00 ±2.82

15.24 ±2.96

16.75 ±1.50

APOE ε4 Dosage (Mean ±std)

0.31 ±0.51

0.62 ±0.68

0.85 ±0.71

0.25 ±0.50

  1. Individuals have been sorted into strata depending on their diagnosis at the baseline visit: healthy control (HC), mild cognitive impairment (MCI), Alzheimer’s Disease (AD), or not applicable for individuals who do not have baseline diagnosis data enclosed (N/A). The mean and standard deviation (std) are provided for the quantitative measures
Back to article page

BMC Genomics

ISSN: 1471-2164

Contact us